.On the heels of an FDA denial for its own main rivalrous Novo Nordisk, Eli Lilly is gaining ground ...
.Merely a couple of months after dosing the 1st patient in a phase 2 trial for freshly identified gl...
.Eli Lilly's hunt for excessive weight targets has actually led it to the dark genome. The Big Pharm...
.Arsenal Biosciences is actually going on up. The tissue therapy business has actually added $325 th...
.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has submitted...
.Aelis Farma's chances of getting a fast, beneficial selection on a $100 thousand alternative settle...
.ProKidney has actually stopped some of a set of period 3 trials for its own cell treatment for rena...
.Vaxcyte introduced what analysts called "impressive" period 1/2 data for its 31-valent pneumococcal...
.Recursion has actually stumbled via a very early exam of its own tech-enabled method to drug revela...
.Contact it a scenario of great chemical make up: Acepodia, a biotech based on Nobel Champion scienc...